AIB1/SRC-3 Deficiency Affects Insulin-Like Growth Factor I Signaling Pathway and Suppresses v-Ha-ras-induced Breast Cancer Initiation and Progression in Mice

Cancer Research

Volumn 64, Issue 5, 2004, Pages 1875-1885

  Kuang, Shao Qing ^a   Liao, Lan ^a   Zhang, Hao ^a   Lee, Adrian V ^a   O'Malley, Bert W ^a   Xu, Jianming ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; INSULIN RECEPTOR; PROGESTERONE; RAS PROTEIN; SOMATOMEDIN C; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; HISTONE ACETYLTRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR RECEPTOR COACTIVATOR 3; PROGESTERONE RECEPTOR; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ESTRUS; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ANIMAL; BREAST TUMOR; CELL DIVISION; CHEMISTRY; DISEASE COURSE; ENZYME ACTIVATION; LUNG TUMOR; METABOLISM; METASTASIS; ONCOGENE RAS; PHYSIOLOGY; UDDER;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; DISEASE PROGRESSION; ENZYME ACTIVATION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENES, RAS; HISTONE ACETYLTRANSFERASES; INSULIN-LIKE GROWTH FACTOR I; LUNG NEOPLASMS; MAMMARY GLANDS, ANIMAL; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; OVARIECTOMY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 1642349331     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3745     Document Type: Article

References (49)

1. Parkin, D. M. Epidemiology of cancer: global patterns and trends. Toxicol. Lett., 102-103: 227-234, 1998.
2. Martin, G., Davio, C., Rivera, E., Melito, G., Cricco, G., Andrade, N., Caro, R., and Bergoc, R. Hormone dependence of mammary tumors induced in rats by intraperitoneal NMU injection. Cancer Invest., 15: 8-17, 1997.
3. Fishman, J., Osborne, M. P., and Telang, N. T. The role of estrogen in mammary carcinogenesis. Ann. N. Y. Acad. Sci., 768: 91-100, 1995.
4. Bocchinfuso, W. P., Hively, W. P., Couse, J. F., Varmus, H. E., and Korach, K. S. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-a. Cancer Res., 59: 1869-1876, 1999.
5. Lydon, J. P., Ge, G., Kittrell, F. S., Medina, D., and O'Malley, B. W. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res., 59: 4276-4284, 1999.
6. Hilakivi-Clarke, L. Estrogens, BRCA1, and breast cancer. Cancer Res., 60: 4993-5001, 2000.
7. Howell, A., Howell, S. J., and Evans, D. G. New approaches to the endocrine prevention and treatment of breast cancer. Cancer Chemother. Pharmacol., 52: S39-44, 2003.
8. McKenna, N. J. and O'Malley, B. W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell, 108: 465-474, 2002.
9. Xu, J., and Li, Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol., 17: 1681-1692, 2003.
10. Huang, Z. Q., Li, J., Sachs, L. M., Cole, P. A., and Wong, J. A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and mediator for transcription. EMBO J., 22: 2146-2155, 2003.
11. Dilworth, F. J., Fromental-Ramain, C., Yamamoto, K., and Chambon, P. ATP-driven chromatin remodeling activity and histone acetyltransferases act sequentially during transactivation by RAR/RXR in vitro. Mol. Cell, 6: 1049-1058, 2000.
12. Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.Y., Sauter, G., Kallioniemi, O. P., Trent, J. M., and Meltzer, P. S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science (Wash. DC), 277: 965-968, 1997.
13. Bautista, S., Valles, H., Walker, R. L., Anzick, S., Zeillinger, R., Meltzer, P., and Theillet, C. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. Clin. Cancer Res., 4: 2925-2929, 1998.
14. Bouras, T., Southey, M. C., and Venter, D. J. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res., 61: 903-907, 2001.
15. List, H. J., Reiter, R., Singh, B., Wellstein, A., and Riegel, A. T. Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue. Breast Cancer Res. Treat., 68: 21-28, 2001.
16. Osborne, C. K., Bardou, V., Hopp, T. A., Chamness, G. C., Hilsenbeck, S. G., Fuqua, S. A., Wong, J., Allred, D. C., Clark, G. M., and Schiff, R. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J. Natl. Cancer Inst., 95: 353-361, 2003.
17. Rebbeck, T. R., Wang, Y., Kantoff, P. W., Krithivas, K., Neuhausen, S. L., Godwin, A. K., Daly, M. B., Narod, S. A., Brunet, J. S., Vesprini, D., Garber, J. E., Lynch, H. T., Weber, B. L., and Brown, M. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res., 61: 5420-5424, 2001.
18. Planas-Silva, M. D., Shang, Y., Donaher, J. L., Brown, M., and Weinberg, R. A. AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Cancer Res., 61: 3858-3862, 2001.
19. List, H. J., Lauritsen, K. J., Reiter, R., Powers, C., Wellstein, A., and Riegel, A. T. Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells. J. Biol. Chem., 276: 23763-23768, 2001.
20. Xu, J., Liao, L., Ning, G., Yoshida-Komiya, H., Deng, C., and O'Malley, B. W. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTRITRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc. Natl. Acad. Sci. USA, 97: 6379-6384, 2000.
21. Sinn, E., Muller, W., Pattengale, P., Tepler, I., Wallace, R., and Leder, P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell, 49: 465-475, 1987.
22. Hundley, J. E., Koester, S. K., Troyer, D. A., Hilsenbeck, S. G., Barrington, R. E., and Windle, J. J. Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors. Cancer Res., 57: 600-603, 1997.
23. Adnane, J., Jackson, R. J., Nicosia, S. V., Cantor, A. B., Pledger, W. J., and Sebti, S. M. Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model. Oncogene, 19: 5338-5347, 2000.
24. Xu, J., Qiu, Y. DeMayo, F. J., Tsai, S. Y., Tsai, M. J., and O'Malley, B. W. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science, 279: 1922-1925, 1998.
25. Zhang, M., Shi, Y., Magit, D., Furth, P. A., and Sager, R. Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice. Oncogene, 19: 6053-6058, 2000.
26. Zhang, H., Liao, L., Kuang, S. Q., and Xu, J. Spatial distribution of the messenger ribonucleic acid and protein of the nuclear receptor coactivator, amplified in breast cancer-3, in mice. Endocrinology, 144: 1435-1443, 2003.
27. Nishihara, E., Yoshida-Komiya, H., Chan, C. S., Liao, L., Davis, R. L., O'Malley, B. W., and Xu, J. SRC-1 null mice exhibit moderate motor dysfunction and delayed development of cerebellar Purkinje cells. J. Neurosci., 23: 213-222, 2003.
28. Yuan, Y., Liao, L., Tulis, D. A., and Xu, J. Steroid receptor coactivator-3 is required for inhibition of neointima formation by estrogen. Circulation, 105: 2653-2659, 2002.
29. Brisken, C., Heineman, A., Chavarria, T., Elenbaas, B., Tan, J., Dey, S. K., McMahon, J. A., McMahon, A. P., and Weinberg, R. A. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev., 14: 650-654, 2000.
30. Yasuda, S., Furuichi, M., and Soeda, E. An altered DNA sequence encompassing the ras gene of Harvey murine sarcoma virus. Nucleic Acids Res., 12: 5583-5588, 1984.
31. Kuang, S. Q., Liao, L., Zhang, H., Pereira, F. A., Yuan, Y., DeMayo, F. J., Ko, L., and Xu, J. Deletion of the cancer-amplified coactivator AIB3 results in defective placentation and embryonic lethality. J. Biol. Chem., 277: 45356-45360, 2002.
32. Couse, J. F., and Korach, K. S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr. Rev., 20: 358-417, 1999.
33. Huseby, R. A., Soares, M. J., and Talamantes, F. Ectopic pituitary grafts in mice: hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas. Endocrinology, 116: 1440-1448, 1985.
34. Hewitt, S. C., Bocchinfuso, W. P., Zhai, J., Harrell, C., Koonce, L., Clark, J., Myers, P., and Korach, K. S. Lack of ductal development in the absence of functional estrogen receptor a delays mammary tumor formation induced by transgenic expression of ErbB2/neu. Cancer Res., 62: 2798-2805, 2002.
35. Mehta, N. M., El-Gewely, M. R., Joshi, J., Helling, R. B., and Banerjee, M. R. Cloning of mouse β-casein gene sequences. Gene, 15: 285-288, 1981.
36. Janes, P. W., Daly, R. J., deFazio, A., and Sutherland, R. L. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene, 9: 3601-3608, 1994.
37. Yu, Q., Geng, Y., and Sicinski, P. Specific protection against breast cancers by cyclin D1 ablation. Nature (Lond.), 411: 1017-1021, 2001.
38. Bowe, D. B., Kenney, N. J., Adereth, Y., and Maroulakou, I. G. Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E. Oncogene, 21: 291-298, 2002.
39. Jordan, V. C., and Dix, C. J. Effect of oestradiol benzoate, tamoxifen and monohydroxytamoxifen on immature rat uterine progesterone receptor synthesis and endometrial cell division. J. Steroid Biochem., 11: 285-291, 1979.
40. Seth, P., Porter, D., Lahti-Domenici, J., Geng, Y., Richardson, A., and Polyak, K. Cellular and molecular targets of estrogen in normal human breast tissue. Cancer Res., 62: 4540-4544, 2002.
41. Lu, R., and Serrero, G. Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC-cell-derived growth factor (PCDGF/granulin precursor). Proc. Natl. Acad. Sci. USA, 98: 142-147, 2001.
42. Hadsell, D. L., and Bonnette, S. G. IGF and insulin action in the mammary gland: lessons from transgenic and knockout models. J. Mammary Gland Biol. Neoplasia, 5: 19-30, 2000.
43. Wang, Z., Rose, D. W., Hermanson, O., Liu, F., Herman, T., Wu, W., Szeto, D., Gleiberman, A., Krones, A., Pratt, K., Rosenfeld, R., Glass, C., K., and Rosenfeld, M. G. Regulation of somatic growth by the p160 coactivator p/CIP. Proc. Natl. Acad. Sci. USA, 97: 13549-13554, 2000.
44. Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., and Brown, M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell, 103: 843-852, 2000.
45. Malaney, S., and Daly, R. J. The ras signaling pathway in mammary tumorigenesis and metastasis. J. Mammary Gland Biol. Neoplasia, 6: 101-113, 2001.
46. Wu, R. C., Qin, J., Hashimoto, Y., Wong, J., Xu, J., Tsai, S. Y., Tsai, M. J., and O'Malley, B. W. Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I κB kinase. Mol. Cell Biol., 22: 3549-3561, 2002.
47. Font de Mora, J., and Brown, M. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol. Cell Biol., 20: 5041-5047, 2000.
48. Sachdev, D., and Yee, D. The IGF system and breast cancer. Endocr. Relat. Cancer, 8: 197-209, 2001.
49. Zhou, G., Hashimoto, Y., Kwak, I., Tsai, S. Y., and Tsai, M. J. Role of the steroid receptor coactivator SRC-3 in cell growth. Mol. Cell. Biol., 23: 7742-7755, 2003.